Uniogen
@upcon.fi
Uniogen will be attending the UPCON 2024 conference with a booth. UPCON, renowned for its focus on the properties, design, and applications of Upconversion Nanomaterials, serves as a vital platform for discussing advances in this field. Bringing together experts from both academia and industry, UPCON encourages a rich exchange of ideas and insights into future trends. Join us in exploring the cutting-edge developments in upconversion nanomaterials at UPCON 2024 and meet us at our booth!
Uniogen's Company Logos
Uniogen's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#E0004D
Razzmatazz
224, 0, 77
339, 100, 44
0, 100, 66, 12
#F190B2
Mauvelous
241, 144, 178
339, 78, 75
0, 40, 26, 5
#3F3F3F
Mine Shaft
63, 63, 63
0, 0, 25
0, 0, 0, 75
About Uniogen
Uniogen is a global leader in clinical diagnostics and point-of-care testing, dedicated to enhancing patient care by enabling diagnosis and treatment from the very first appointment. Established in 2022 through the merger of Abacus Diagnostica, Kaivogen, and Labrox, Uniogen harnesses advanced technologies to offer rapid and cost-effective diagnostic solutions. Their flagship products include the GenomEra® rapid PCR tests for infectious diseases, notably SARS-CoV-2, and innovative Upcon™ labeling technology that ensures high sensitivity in testing.
The company specializes in cancer diagnostics and provides a range of laboratory instruments, reagents, and contract manufacturing services designed to meet diverse healthcare needs. Uniogen is currently developing a groundbreaking glycovariant immunoassay for early ovarian cancer detection and a complete point-of-care testing solution that facilitates simultaneous diagnosis of multiple diseases with ease. Headquartered in Turku, Finland, Uniogen’s products are available in approximately 100 countries, positioning the brand at the forefront of the global diagnostics market.
Company type
Partnership
Year founded
2014
Company size
11-50 employees
